1. Overview
  2. All Stocks
  3. ICON PLC

ICON (ICLR.US) Price Target 2026/2027: 15% Upside – Rating and Stock Analysis

160,77
-1,68%
Analysis framework by , founder of TradeDesk · Data: EODHD, official filings (SEC) · Updated
Price history for ICON (ICLR.US) – stock price at 160.77 $, August 2026
ICON stock price – price development 2026. Updated Aug 6, 2026.
Share this analysis:

ICON Price Target 2026: Analysts See 15% Upside

The average price target for ICON is $185.56. This price target represents the analysts' view of the stock price over the next 12 months. The stock may be undervalued, because the price target is higher than the current price. The stock is 15,42% below the target, which can point to potential returns within the next 12 months if the analysts' view proves right. Also consider the stock's valuation ratios such as P/E, P/S and P/B, plus the technical analysis further down the page, for the full picture.

Is ICON overvalued or undervalued?

ICON is currently undervalued with a gap of 15.4% relative to the price target.


The current price is $160.77, which places ICON in the undervalued category. The stock is considered undervalued when the price is below $167.00, and overvalued when the price exceeds $204.12.


The fair value range is defined as ±10% of the price target, because price targets are estimates rather than exact values. For ICON, the fair value range lies between $167.00 and $204.12.


See the full price target analysis for ICON →

↑ Back to navigation

Analyst Ratings for ICON stock in 2026: Buy

17 analysts cover ICON. The majority is positive, with 64.7% recommending Buy, while 35.3% recommend Hold. The average price target is $185.56, which gives an upside of 15.4% from the current price.

Consensus: Buy (4.29/5)
Strong Buy
11 (64.7%)
Hold
6 (35.3%)
Strong Sell Sell Hold Buy Strong Buy
4.29 out of 5 based on 17 analysts
↑ Back to navigation

About ICON – Diagnostics & Research

ICON, eller iclr.us, driver en stor, global forretning, hvor de hjælper medicinalfirmaer med at udvikle nye lægemidler. De tjener penge på at levere outsourcing-ydelser til klinisk forskning, fra de første test til det færdige produkt. ICON specialiserer sig i at styre alle faser af de kliniske forsøg, altså Phase I-IV studier. De tilbyder en række services, for eksempel håndtering af data, biostatistik og klinisk operationsstyring. Det er en kompleks proces, og de har laboratorier og specialister i Irland, USA og mange andre lande. Virksomheden blev grundlagt i 1990 og har siden bygget en solid platform for at understøtte den globale lægemiddeludvikling. Read more about the company

Key Figures for ICON

$ 12,1B Market cap
$ 8,3B Revenue
Diagnostics & Research Industry
241.31 P/E
1.46 P/S
1.35 P/B
USA Listed on exchange
iconplc.com Website
Sundhed Sector

What kind of stock is ICON?

Speculative stock

ICON is classified as a speculative stock.

Score Overview for ICON

💰 Value Score 44/100 (Neutral)
⭐ Quality Score 39/100 (Low)
🚀 Momentum Score 62/100 (High)
📊 Total Score 48/100

⚠️ 1 red flag identified 1 critical

Our analysis has identified 1 potential risk factor in ICON that investors should be aware of.

🚨 Falling earnings: Quarterly earnings have fallen 63% year over year – the company's profitability is under pressure.

📈 Valuation

ICON trades at a P/E ratio of 241.3, which is above the market average. The forward P/E is 15.6 (94% lower), which suggests the market expects rising earnings. The P/S ratio is 1.5. The P/B ratio is 1.3. The PEG ratio is 0.53 — below 1.0 suggests the stock is cheap relative to its growth rate.

💵 Profitability & Growth

ICON has a profit margin of 0.3% (moderate) and an operating margin of 9.4%. Return on equity (ROE) is 0.3%. Return on assets (ROA) is 1.0%. The latest quarterly earnings grew -63.3% year over year — falling earnings.

🏦 Financial Health

The Piotroski score is 6 out of 9 — good financial health. Altman Z2 is 2.06 (middle zone — moderate). The debt-to-equity ratio (D/E) is 77.2% — low debt, a solid balance sheet.

🚀 Momentum & Short Interest

Short interest is 3.80%.

↑ Back to navigation

ICON Short Selling 2026: 3.8% Sold Short

Moderate short interest: 3.8% of the free float
Short % of free float
3.8%
Assessment
Moderate short interest
Short squeeze risk
Low
Data source
SEC
Updated daily
The stock has a moderate share of short selling. Between 2-5% of the freely traded shares are sold short, which is within the normal range for most stocks.

Data is updated daily based on official filings with the SEC.
Short Interest Scale
0% 2% 5% 10% 20%+
Low Moderate High Very High Extreme
▲
3.8%

↑ Back to navigation

When Does ICON Report Earnings?

The next earnings date for ICON is not yet available. Check the company's investor calendar for more information.



↑ Back to navigation

Technical Analysis of ICON 2026 – Signal: Strong Buy

Overall Technical Signal: Strong Buy

Based on trend analysis (SMA50/SMA200) and MACD trend (positive/negative on a daily + weekly basis). Updated August 6, 2026.

Technical analysis of ICON (ICLR.US) – RSI 50, MACD positive (bullish), daily candlestick chart August 2026
ICON technical analysis – candlestick chart with RSI and MACD. Updated Aug 6, 2026.

Trend Analysis of ICON PLC

ICON PLC is in a short-term downtrend. The price of $163.51 is 2.5% below the 20-day average ($167.69). Medium term, the picture is positive: the price is 3.8% above the 50-day average ($157.57). Long term, the stock is 10.6% above the 200-day average ($147.84), which confirms a long-term uptrend.

Golden Cross: The 50-day average (157.57) is above the 200-day average (147.84), which is a classic bullish signal for ICON PLC.

Is ICON PLC overbought or oversold?

ICON PLC has an RSI of 49.6, right in the middle of the neutral zone. There is no clear buying or selling pressure.

MACD Analysis for ICON PLC

Daily MACD: MACD is positive (1.293), which means the short-term trend is bullish (the 12-day EMA is above the 26-day EMA). MACD is below the signal line (3.508) by 2.215, which suggests the positive momentum is fading – the trend could be turning.

Weekly MACD: MACD5 is positive (6.765), which indicates a broader bullish long-term trend. MACD5 is above the signal line (0.003) by 6.762, which confirms rising long-term momentum.

Overall MACD assessment: Both the daily and weekly trend are bullish (MACD positive). However, momentum shows signs of weakening on a daily basis. Watch whether the trend holds.

Risk Profile for ICON PLC

ICON PLC has an annual standard deviation of 67.5%, which classifies the stock as high risk. Sizeable price swings are normal, and the stock requires a higher risk tolerance.

Overall Technical Conclusion for ICON PLC

Trend: Positive. The price trades above SMA50 and SMA200.

MACD trend (zero line): Daily bullish (1.293). Weekly bullish (6.765).

MACD momentum (signal): Daily falling. Weekly rising.

RSI: 49.6 – neutral.

Technical signal: Strong Buy

The price is in an uptrend (above SMA50/SMA200) and MACD is positive on both a daily and weekly basis. Trend and MACD trend confirm each other – the strongest technical buy signal.

↑ Back to navigation

Frequently Asked Questions About ICON stock in 2026

Should you buy ICON stock now?
Yes, the technical signal for ICON is currently BUY. ICON trades at $160.77 as of 8/6/2026. The overall technical signal is: Strong Buy. The technical analysis shows the following: MACD is positive (bullish trend) at 1.293 with falling momentum (signal: 3.508); RSI is at 49.6 (neutral zone); the stock is in a short-term downtrend (price below the 20-day average); the analyst price target of $185.56 points to 15.4% upside. The stock is in a broader uptrend (above SMA50/SMA200). This is a technical observation based on current data, not investment advice.
What is the price target for ICON stock?
The average analyst price target for ICON is $185.56. The current price is $160.77, which gives an upside of 15.4%. Based on this, the stock is considered undervalued. The fair value range (±10% of the price target) is between $167.00 and $204.12.
Is ICON a dividend stock?
No, ICON does not currently pay a dividend to shareholders. The company reinvests its profits in growth instead of paying dividends.
What is the risk of ICON stock?
ICON is rated as a stock with high risk. the annual standard deviation is 67.5%, which classifies the stock as high risk.
Is ICON overvalued?
No, ICON is considered undervalued based on the analyst price target (15.4% upside). ICON has the following valuation ratios: a P/E ratio of 241.3 (highly valued), a P/S ratio of 1.5, a P/B ratio of 1.3. The analyst price target suggests that the stock is undervalued by 15.4%.
Is ICON overbought?
No, ICON is not overbought. RSI is at 49.6 (neutral zone). The technical indicators show: RSI is at 49.6 (neutral zone between 30-70), which signals neither overbought nor oversold. In addition, the price is 4.1% below the 20-day average (short-term downtrend). In addition, MACD is positive, but momentum is falling.
When is the next ICON earnings report?
The date of the next earnings report for ICON has not been published yet. Check the company's investor calendar for updates.
Is ICON shorted?
Yes, ICON is shorted with 3.8% of the free float sold short. This is a moderate level of short selling, within the normal range for most stocks. Data is updated daily based on official filings with the SEC.
Are insiders buying ICON stock?
There is currently no registered insider trading for ICON.
Is ICON a good stock?
Based on our total score, ICON is rated as a mediocre stock with a total score of 48 out of 100. The stock scores around average on value, quality and momentum – it sits near the median in our database. The score is made up of Value: 44/100, Quality: 39/100, Momentum: 62/100. In addition: analysts see 15.4% upside to the price target; technical signal: Strong Buy. Whether ICON is a good investment depends on your time horizon, risk profile and portfolio. This is a data-driven observation, not investment advice.
What is the outlook for ICON stock?
The outlook for ICON based on current data: the average analyst price target is $185.56 (+15.4%); the stock is in an uptrend (above SMA50 and SMA200); the P/E ratio is 241.3 (high – the market expects growth). Keep in mind that stock prices are affected by many factors, including earnings reports, the economy and market sentiment. Past returns are no guarantee of future returns.
Why is ICON stock falling?
ICON is falling right now. The technical indicators show: the price is 4.1% below the 20-day average. For the latest context, see our technical analysis, insider section and news overview above.
How high can ICON go?
The average analyst price target for ICON is $185.56, which corresponds to a potential gain of 15.4% from the current price of $160.77. Keep in mind that price targets are estimates, not guarantees. Actual price moves depend on earnings, market conditions and unexpected events.
How low can ICON fall?
We lack enough history to give a specific floor for ICON. Remember: past price swings are no guarantee for the future — a stock can fall further than the last 52 weeks suggest, especially on profit warnings, sector crises or a market crash. Use stop-loss orders and spread your portfolio to limit losses in single stocks.
What does ICON do?
ICON, eller iclr.us, driver en stor, global forretning, hvor de hjælper medicinalfirmaer med at udvikle nye lægemidler. De tjener penge på at levere outsourcing-ydelser til klinisk forskning, fra de første test til det færdige produkt. ICON specialiserer sig i at styre alle f... The company belongs to the Sundhed sector, more specifically the Diagnostics & Research industry, is headquartered in USA, and is traded on the USA Stocks. See the key figures, earnings history and price development above to evaluate ICON as an investment.
Did ICON raise or lower its guidance?
Over the last 60 days we have not registered a guidance raise or cut from ICON. The company can still adjust its guidance at quarterly reports or between reports — see the earnings history and the news overview above.
Is ICON making money or losing money?
Yes, ICON is making money, not losing it. The company has a profit margin (the share of revenue left over as profit) of 0.3% — which is modest. The operating margin (profit before interest and taxes) is 9.4%. At a P/E ratio of 241.3, you currently pay 241.3 dollars for every dollar of the company's annual earnings. A consistently profitable company is usually more resilient than growth stocks that are not yet making money.
Can ICON go bankrupt?
The bankruptcy risk of ICON is rated as moderate. Altman Z2 (a model for assessing financial distress) is 2.06 — that places the company in the middle zone. The Piotroski score (financial health 0-9, higher is better) is 6 — which is average. Debt relative to equity is 77% (moderate). Remember: models like Altman Z2 are statistical — unexpected shocks (fraud, a sector collapse, lawsuits) can always happen. Spread your portfolio.
Does ICON have a lot of debt?
No, ICON has low debt relative to equity. The debt-to-equity ratio (D/E — interest-bearing debt to equity) is 77%. For the sundhed sector, anything below 80% counts as low debt. Note: D/E levels are highly sector-specific — a bank at 300% debt is normal, a tech stock at 300% is extremely leveraged. Always compare with similar companies in the same sector. Can ICON service its debt? Can service its debt, but it weighs on the company — the interest coverage ratio (how many times earnings can cover interest payments) is 4.0x, and net debt equals 4.9 years of earnings (EBITDA).
↑ Back to navigation

Explore More